University of Wisconsin, Madison
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Wisconsin, Madison sits in the top decile of US sponsors by registered trial count (#31 of 15,742 sponsors by registered trial count).
University of Wisconsin, Madison: 1,039 sponsored US clinical trials, 151 recruiting.
University of Wisconsin, Madison sponsors 1,039 registered US clinical trials on ClinicalTrials.gov, 151 of them currently recruiting, and 712 completed. 98 of these trials are in Phase 3-4 (later-stage) and 251 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 10 trials.
Top-decile sponsor footprint
University of Wisconsin, Madison ranks in the top decile of sponsors by registered trial count (#31 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
712 of 824 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,039 total, page 15 of 21
Striving to Quit: First Breath
NCT01569490
Psychological Effects of Tai Chi Training
NCT01681082
A Comparison of Tumescence in Breast Reduction Surgery
NCT01602692
University of Wisconsin Meditation & Exercise Cold Study
NCT01654289
FLT-PET Imaging for MDS
NCT01535456
Study of 124I-NM404 in Advanced Solid Malignancies
NCT01662284
Study of Cardiovascular Disease and Obstructive Sleep Apnea
NCT01637623
Docetaxel +/- Suramin in 2nd Line Advanced Non-Small Cell Lung Cancer
NCT01671332
A Comparative Effectiveness & Long Term Health Study in Wisconsin Smokers
NCT01553084
Air-Q® SP Versus Air-Q® and I-gel: A Randomized Clinical Trial
NCT01592760
How Does Magnesium Status Influence Calcium Homeostasis?
NCT01593501
Prospective Trial of the Effect of Preoperative Forced-air Warming on Perioperative Body Temperature Following Neuraxial Anesthesia in Total Hip Arthroplasty Patients
NCT01626690
Peripheral Vasodilation in Obese Humans
NCT02833207
Study of Tongue Strengthening for Swallowing Problems
NCT01570023
Complementary and Alternative Interventions for Veterans With Posttraumatic Stress Disorder
NCT01512303
Duration of Analgesic Effect for Ultrasound Guided Supraclavicular Blocks With the Addition of Buprenorphine to Local Anesthetic Solution
NCT01583179
To Test a Payer/Treatment Agency Intervention to Increase Use of Buprenorphine
NCT01702142
Pharmacodynamic Study With FLT-PET/CT in Patients With Prostate/Other Solid Malignancies Treated With High Dose Axitinib
NCT01540526
PET/CT Evaluation of Primary and Metastatic Brain Tumors With a Novel Radioiodinated Phospholipid Ether Analogue I-NM404
NCT01540513
Vitamin A Liver Reserves and Serum Markers of Vitamin A in US Adults at Time of Death
NCT03305042
Attention Training
NCT01518738
Meriter Mindfulness Training for Smokers Program and Study
NCT02143752
Propranolol for Diabetic Retinopathy
NCT01535495
Quality of Life Study Using Gabapentin Versus Venlafaxine in Treating Hot Flashes in Patients With Prostate Cancer
NCT01533753
Non-invasive Quantification of Liver Iron With MRI
NCT01516853
Sinusitis in Children and the Nasopharyngeal Microbiome
NCT01492868
African American Depression Intervention Trial (AADI)
NCT01342536
PET/CT Imaging of Malignant Brain Tumors With 124I-NM404
NCT01516905
Improving the Understanding of the Response to Vitamin D Supplementation
NCT01465178
A Biological Study of Resveratrol's Effects on Notch-1 Signaling in Subjects With Low Grade Gastrointestinal Tumors
NCT01476592
Sodium Fluoride (NaF) Positron Emission Tomography/Computed Tomography (PET/CT) in Patients With Metastatic Castrate-resistant Prostate Cancer (CRPC) With Microtubule Directed Chemo or AR-directed Therapy
NCT01516866
The Effect of Solifenacin on Post Void Dribbling in Women
NCT01470001
Effect of Cancer Nurse Navigators on Patient Outcomes
NCT01902823
Mycophenolic Acid (MPA) Monotherapy in Liver Transplantation
NCT01230502
Neural Mechanisms in Asthma
NCT01155843
Evaluation of National Cancer Institute (NCI) Smoking Intervention Resources
NCT01342523
Transversus Abdominis Plane Blocks for Patients Undergoing Robotic Gynecologic Oncology Surgery
NCT01444924
University of Wisconsin hMSC Cell Bank: Bone Marrow Donor Protocol
NCT01463475
Phase 2 Study of Glycomacropeptide Versus Amino Acid Diet for Management of Phenylketonuria
NCT01428258
Functional Activity of Airway Eosinophils in Allergic Disease
NCT01026532
Post-Operative Colonization Rates of Femoral Nerve Catheters Treated With Chlorhexidine-Impregnated Patch
NCT01411891
Evaluation of The Vaginal Renewal™ Program in Gynecologic Cancer Patients Experiencing Sexual Dysfunction
NCT01444911
Transversus Abdominis Plane Blocks for Ileostomy Takedown: A Prospective Study
NCT01411917
Sunweavers: Supporting Native American Women's Vitamin D Research
NCT01490333
Bring Communities and Technology Together for Healthy Aging
NCT02128789
Dose Dense TC + Pegfilgrastim Support for Breast Cancer
NCT01671319
Prospective Evaluation of Interscalene Nerve Catheters vs. Single Injection Blocks
NCT01385449
Phase II PAP Plus GM-CSF Versus GM-CSF Alone for Non-metastatic Prostate Cancer
NCT01341652
Matching Cognitive Remediation to Cognitive Deficits in Substance-Abusing Inmates
NCT01428349
Human Factors Intervention to Reduce Risk in Primary Care of the Elderly
NCT01326637
What is open in the University of Wisconsin, Madison pipeline
151 recruiting of 1,039 indexed (15% open); 712 completed (69%).
Phase mix: 98 late (III/IV) vs 251 early (I/II) (early-phase heavy).
Top condition: Healthy (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Wisconsin, Madison: open-pipeline peers nationwide
Peers matched on 1,039 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Wisconsin, Madison sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,039 trials (± recruiting share)
- University of Washington · 1,048 trials · 15% recruiting
- Bristol-Myers Squibb · 1,025 trials · 7% recruiting
- University of Florida · 1,106 trials · 15% recruiting
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Masonic Cancer Center, University of Minnesota · 14% recruiting · 249 trials
- ModernaTX · 14% recruiting · 90 trials
- United States Naval Medical Center, San Diego · 15% recruiting · 41 trials
- The Cleveland Clinic · 14% recruiting · 688 trials
Related
What to do with this University of Wisconsin, Madison page
1,039 registered trials is a research-attention snapshot, not an endorsement of University of Wisconsin, Madison or any single study.
- 151 of University of Wisconsin, Madison's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy is the condition University of Wisconsin, Madison studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Wisconsin, Madison pipeline card: 1,039 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.